NEW YORK (GenomeWeb News) – Cancer Genetics today announced it has reached a deal with a second preferred provider organization.
The Rutherford, NJ-based firm has executed an agreement with Three Rivers Provider Network, providing about 15 million of the PPO's members access to Cancer Genetics' testing menu. The deal follows an agreement that Cancer Genetics inked with MultiPlan in May 2013.
Cancer Genetics CEO Panna Sharma said in a statement that the deal with Three Rivers means that a total of 72 million individuals in the US now have access to Cancer Genetics' tests as a covered benefit.
Three Rivers has more than 550,000 healthcare providers, including more than 5,000 hospitals and 70,000 ancillary facilities.